Hirotaka Ebina

1.8k citations
36 papers · 1.4k indexed · 1 hit paper · h-index 17
Topics
CRISPR and Genetic Engineering (9 papers)SARS-CoV-2 and COVID-19 Research (7 papers)HIV Research and Treatment (7 papers)
Partner nations
JapanUnited StatesFrance

In The Last Decade

Hirotaka Ebina

32 papers receiving 1.4k citations

Hit Papers

Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1...20132026201720212013100200300400

Peers

Hirotaka Ebina
Comparison fields: 5 of 71
  • Molecular Biology 942
  • Virology 373
  • Plant Science 317
  • Infectious Diseases 255
  • Genetics 195
Replace Kristine E. Yoder with:
Kristine E. Yoder United States
Yaw Shin Ooi United States
Qinghua Pan Canada
Jeremy Koob United States
Bep Klaver Netherlands
Jill M. Perreira United States
Andrew Varble United States
George Savidis United States
Rennos Fragkoudis United Kingdom
Frank Radecke Germany
Hirotaka Ebina relative to Kristine E. Yoder United States Kristine E. Yoder's profile →
Citations per field
00.5×4.0×
Kristine E. Yoder · 1×
Citations per year

Countries citing papers authored by Hirotaka Ebina

Since Specialization
Citations

This map shows the geographic impact of Hirotaka Ebina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirotaka Ebina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirotaka Ebina more than expected).

Fields of papers citing papers by Hirotaka Ebina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hirotaka Ebina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirotaka Ebina. The network helps show where Hirotaka Ebina may publish in the future.

Co-authorship network of co-authors of Hirotaka Ebina

This figure shows the co-authorship network connecting the top 25 collaborators of Hirotaka Ebina. A scholar is included among the top collaborators of Hirotaka Ebina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hirotaka Ebina. Hirotaka Ebina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 2
3 0
4 3
5 3
6 7
7 31
8 4
9 52
10 87
11 3
12
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirusbreakdown →
431
13 20
14 31
15 6
16 47
17 16
18 137
19 53
20 3

About Hirotaka Ebina

Hirotaka Ebina is a scholar working on Virology, Infectious Diseases and Dermatology, having authored 36 papers that have together received 1.4k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and HIV Research and Treatment (7 papers). The work is most often cited by research in Virology (373 citations), Business and International Management (93 citations) and Infectious Diseases (255 citations). Hirotaka Ebina has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Yoshio Koyanagi, Naoko Misawa, Yuka Kanemura, Henry L. Levin, Shiv I. S. Grewal, Daniel F. Voytas, Yi Hou, Xiang Gao, Takeshi Yoshida and Ken-ichi Noma. Their work appears in journals such as Nature, Journal of Biological Chemistry and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026